Skip to main navigation Skip to search Skip to main content

Parity and prognosis in breast cancer

  • Angelos E. Papatestas
  • , Michael Mulvihill
  • , Catherine Josi
  • , John Ioannovich
  • , Gerson Lesnick
  • , Arthur H. Aufses

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Abstract

Analysis of five‐year disease‐free survival rates in 608 women with operable breast cancer revealed that the reproductive history is a significant prognostic determinant. Overall parous women had a significantly higher cumulative five‐year disease‐free survival rate (60%), compared to the nulliparous (46%) (z = 2.5, p = 0.012). Significant differences were also noted when gravidity in addition to parity was taken as the determinant. The corresponding disease‐free survival rates were 61% and 50%, respectively (z = 1.98, p = 0.048). Five‐year survival rates were influenced in a similar manner by these variables but the observed differences were less significant. The trend toward higher survival rates in parous and gravidae women were noted in all tumor stages but achieved statistical significance only in stage III. The findings indicate that parity and gravidity affect not only the risk of breast cancer development but also the subsequent course of the disease. Parity seems to be a stronger risk and prognostic factor than gravidity.

Original languageEnglish
Pages (from-to)191-194
Number of pages4
JournalCancer
Volume45
Issue number1
DOIs
StatePublished - 1 Jan 1980
Externally publishedYes

Fingerprint

Dive into the research topics of 'Parity and prognosis in breast cancer'. Together they form a unique fingerprint.

Cite this